Bayer, Raptor reel in endorsements from EMA for new therapies

Ryan McBride

The European Medicines Agency's experts have backed approval for two drugs that have already gained green lights for the U.S. market.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS